* Silk Road Medical Inc SILK.OQ reported a quarterly
adjusted
loss of 43 cents per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 46 cents per share.
* Revenue rose 25.4% to $33.17 million from a year ago;
analysts
expected $31.03 million.
* Silk Road Medical Inc's reported EPS for the quarter was a
loss
of 44 cents.
* The mean earnings estimate of analysts had fallen by
about 30.8%
in the last three months.
* In the last 30 days two analysts negatively revised
earnings
estimates
* Silk Road Medical Inc shares had risen by 14.3% this
quarter and
lost 2.3% so far this year.
* The company reported a quarterly loss of $15.4 million.
* Wall Street's median 12-month price target for Silk Road
Medical
Inc is $43.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from Refinitiv data July 26
at 10:09 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.46 -0.43 Beat
Mar. 31 2022 -0.37 -0.48 Missed
Dec. 31 2021 -0.36 -0.42 Missed
Sep. 30 2021 -0.30 -0.40 Missed